— GLP-1 / GIP Dual Agonist
Tirzepatide

Apex of metabolic research - the dual-incretin standard.
Tirzepatide is a dual GLP-1 and GIP receptor agonist representing the current global standard for metabolic and weight-management research. Synthesized via solid-phase Fmoc chemistry and purified by reverse-phase HPLC. Available in 5mg, 15mg, and 30mg research-grade lyophilized vials.
Spec
5mg / 15mg / 30mg - Lyophilized
Mass
5.04-30.12 mg
Purity
99.6%
Co-activates GLP-1R and GIPR pathways modulating incretin response and hepatic glucose output in vitro.
Reconstitute with 2 mL bacteriostatic water for a 2.5-15 mg/mL working concentration depending on vial size.
Store lyophilized at -20 deg C. Once reconstituted, refrigerate at 2-8 deg C and use within 28 days.
Select SKU
Price · Per Vial
$16.00
5mg
Research & Operations
Frequently Asked Questions
Clinical-grade answers to the questions that matter most in advanced research procurement.